Bangkok Dusit Medical Services PCLBDULF 65 EBITDA Margin % is 25.07% as of Mar. 2026, which is 1% above its 10-year median of 24.88. GuruFocus rates BDULF with a GF Scoreâ„¢ of 65/100 and a GF Valueâ„¢ of $0.98 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Bangkok Dusit Medical Services PCL ranks better than 83.68% on this metric.
Bangkok Dusit Medical Services PCL (OTCPK:BDULF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bangkok Dusit Medical Services PCL EBITDA Margin % Related Terms
Bangkok Dusit Medical Services PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL EBITDA Margin % Chart
BDULF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Bangkok Dusit Medical Services PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Dusit Medical Services PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bangkok Dusit Medical Services PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bangkok Dusit Medical Services PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Dusit Medical Services PCL (BDULF) has a EBITDA Margin % of 25.07% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bangkok Dusit Medical Services PCL and its competitors. This is near median its historical median of 24.88. Over the past decade, Bangkok Dusit Medical Services PCL's EBITDA Margin % has ranged from 23.70 to 32.11. According to the industry distribution chart, Bangkok Dusit Medical Services PCL ranks #109 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 16.3%.
Is Bangkok Dusit Medical Services PCL's EBITDA Margin % too high?
Bangkok Dusit Medical Services PCL's current EBITDA Margin % of 25.07% is near median its 10-year median of 24.88. Over the past 10 years, this metric has ranged from a low of 23.70 to a high of 32.11. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Bangkok Dusit Medical Services PCL's value of 25.07% is 145.5% above this industry median. Based on the distribution chart, Bangkok Dusit Medical Services PCL ranks #109 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bangkok Dusit Medical Services PCL has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bangkok Dusit Medical Services PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bangkok Dusit Medical Services PCL ranks #109 out of 668 companies for EBITDA Margin %. This places Bangkok Dusit Medical Services PCL in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Bangkok Dusit Medical Services PCL's value of 25.07% is 145.5% above this benchmark. Historically, Bangkok Dusit Medical Services PCL's own EBITDA Margin % has ranged from 23.70 to 32.11 over the past decade. While the company's 10-year median is 24.88 vs. the industry median of 10.21, Bangkok Dusit Medical Services PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Dusit Medical Services PCL's current EBITDA Margin % of 25.07% is 145.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bangkok Dusit Medical Services PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Dusit Medical Services PCL's current EBITDA Margin % is 25.07%, which is near median its own 10-year median of 24.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Dusit Medical Services PCL stock overvalued right now?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL (BDULF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.98, compared to a current price of $0.56 — trading 42.9% below its estimated fair value. The current EBITDA Margin % is 25.07%, which is near median its 10-year median of 24.88 and 145.5% above the Healthcare Providers & Services industry median of 10.21. Bangkok Dusit Medical Services PCL's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bangkok Dusit Medical Services PCL (BDULF), the current EBITDA Margin % is 25.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bangkok Dusit Medical Services PCL (BDULF) Overvalued in 2026?
Based on GuruFocus' analysis, Bangkok Dusit Medical Services PCL stock appears to be undervalued.
The current stock price of $0.56 is trading 42.9% below its estimated GF Value™ of $0.98.
GuruFocus considers Bangkok Dusit Medical Services PCL to be Significantly Undervalued.
Key valuation signals for BDULF:
EBITDA Margin %: 25.07% (near median its 10-year median of 24.88)
GF Value™: $0.98 vs. price of $0.56 (42.9% below fair value)
Industry Position: 145.5% above the Healthcare Providers & Services median (#109 of 668)
No single metric tells the full story. See the BDULF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bangkok Dusit Medical Services PCL Business Description
Bangkok Dusit Medical Services PCL operates a network of private hospitals in Thailand and some overseas markets, under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments, namely hospital operations and other businesses that support hospital business, such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The company's hospital operations generate the vast majority of its revenue.
65GF Score
Get the complete analysis for BDULF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDULF has been successfully added to your 
